The Pfizer-BioNTech COVID-19 vaccine generated antibody responses three-and-a-half times larger in older people when a second dose was delayed to 12 weeks after the first, a British study says. https://t.co/Ci5njtcVqz

— CBC News (@CBCNews) May 14, 2021